Dr. Koyfman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
# Radiatio
Cleveland, OH 44195Phone+1 216-444-1941Fax+1 216-445-1068
Education & Training
- Cleveland Clinic FoundationResidency, Radiation Oncology, 2006 - 2011
- Yale School of MedicineClass of 2006
Certifications & Licensure
- OH State Medical License 2006 - 2026
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck Start of enrollment: 2017 May 10
Publications & Presentations
PubMed
- 2 citationsPrevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline Clinical Insights.Deborah Saunders, Shlomo A Koyfman, Nofisat Ismaila, Neal D Futran, Yvonne M Mowery
JCO Oncology Practice. 2024-12-01 - Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study.Emily E Granger, Nina A Ran, Morgan K Groover, Shlomo A Koyfman, Allison T Vidimos
Journal of the American Academy of Dermatology. 2024-11-01 - 1 citationsAssociation of a 40-Gene Expression Profile With Risk of Metastatic Disease Progression of Cutaneous Squamous Cell Carcinoma and Specification of Benefit of Adjuvant R...Sarah T Arron, Javier Cañueto, Jennifer Siegel, Alison Fitzgerald, Anesh Prasai
International Journal of Radiation Oncology, Biology, Physics. 2024-11-01
Journal Articles
- Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and ToxicityBrian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research
Lectures
- Preliminary safety results of a phase II study investigating pembrolizumab in combination with postoperative intensity modulated radiotherapy (IMRT) in resected high r...2019 ASCO Annual Meeting - 6/1/2019
- Nodal Disease in HPV-Positive and HPV-Negative Cancer: Who Needs Postoperative Radiation?2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Press Mentions
- When to Pursue More Aggressive Treatment for Patients with T1-2a Cutaneous Squamous Cell CarcinomaOctober 3rd, 2024
- A Call for More Interdisciplinary and Preventive Care in New Osteoradionecrosis GuidelinesJuly 8th, 2024
- New Imaging Score May Predict Chemo Benefit in Early OPSCCJanuary 27th, 2023
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Head & Neck Cancer, American College of Radiology 2015 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: